University of Michigan Medical School, Ann Arbor, MI, USA.
Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI, USA.
Ann Surg Oncol. 2021 Feb;28(2):950-957. doi: 10.1245/s10434-020-08961-1. Epub 2020 Jul 30.
For women older than 70 years with early-stage breast cancer, the routine use of sentinel lymph node biopsy (SLNB) and adjuvant radiotherapy offers no overall survival benefit and may be perceived as undesirable by many women. National guidelines allow possible omission of these practices for older women. This study aimed to assess the availability of web-based educational materials targeting older women and their age-specific treatment recommendations.
The study systematically assessed the websites of the top 25 "Best Hospitals for Cancer" ranked by the U.S. News & World Report, as well as the websites of four prominent national cancer organizations.
Websites for the leading cancer hospitals and national cancer organizations contain extremely limited information directed toward older patients with breast cancer. Both SLNB and adjuvant radiotherapy are described as treatments "typically," "most often," or "usually" used in combination with breast-conserving surgery without circumstances noted for possible omission. Specifically, no hospital website and only one national organization in this study included information on the recommendation to avoid routine SLNB. Only two hospitals and two national organizations included information suggesting possible omission of adjuvant radiotherapy for patients older than 70 years.
The absence of online material for older patients with breast cancer represents a gap potentially contributing to overtreatment by framing SLNB and adjuvant radiotherapy as necessary. Informational resources available to women aged 70 years or older may aid in informed physician-patient communication and decision-making, which may reduce SLNB and adjuvant radiotherapy for patients who might opt out of these procedures if fully informed about them.
对于 70 岁以上早期乳腺癌女性患者,常规使用前哨淋巴结活检(SLNB)和辅助放疗并不能带来总体生存获益,而且可能会被许多女性认为不理想。国家指南允许对老年女性可能选择省略这些治疗方法。本研究旨在评估针对老年女性的基于网络的教育材料的可用性及其针对特定年龄的治疗建议。
本研究系统地评估了美国新闻与世界报道排名前 25 的“最佳癌症医院”的网站,以及四个主要国家癌症组织的网站。
领先癌症医院和国家癌症组织的网站仅包含针对老年乳腺癌患者的极其有限的信息。SLNB 和辅助放疗均被描述为与保乳手术联合使用的“通常”、“最常”或“通常”治疗方法,没有说明可能省略的情况。具体来说,没有一家医院网站,本研究中只有一个国家组织包括有关建议避免常规 SLNB 的信息。只有两家医院和两家国家组织提供了信息,建议对 70 岁以上的患者可能选择省略辅助放疗。
针对老年乳腺癌患者的在线信息缺失可能导致过度治疗,因为 SLNB 和辅助放疗被视为必要的治疗方法。为 70 岁或以上的女性提供的信息资源可能有助于医生和患者之间进行知情沟通和决策,这可能会减少那些如果充分了解这些程序就可能选择不接受这些治疗的患者的 SLNB 和辅助放疗。